Product Description
| Ceftazidime capsule |
250mg/500mg |
10tablet/blister,alu-blister /alu-alu |
USP |
|
|
|
|
|
|
|
|
AI Product Description
*The following content is generated by AI and is for reference only.
Ceftazidime capsules represent a specialized oral formulation of a third-generation cephalosporin antibiotic, primarily indicated for the treatment of moderate to severe bacterial infections caused by susceptible organisms. While ceftazidime is most commonly administered intravenously or intramuscularly in clinical settings due to its pharmacokinetic profile, oral capsules are utilized in specific therapeutic contexts where parenteral therapy is no longer required or when transitioning from initial IV treatment to an oral step-down regimen. This medication is particularly effective against Gram-negative bacteria, including *Pseudomonas aeruginosa*, *E. coli*, *Klebsiella*, and *Proteus* species, making it valuable for treating respiratory tract infections, urinary tract infections, skin and soft tissue infections, as well as bone and joint infections.
The primary mechanism of action involves inhibiting bacterial cell wall synthesis, leading to cell lysis and death. Patients prescribed Ceftazidime capsules must adhere strictly to the dosage schedule to ensure therapeutic efficacy and prevent the development of antibiotic resistance. It is crucial to complete the full course of treatment even if symptoms improve significantly before the medication is finished. Common side effects may include gastrointestinal disturbances such as nausea, vomiting, diarrhea, and abdominal pain. More serious adverse reactions, though rare, can involve allergic responses ranging from mild rashes to life-threatening anaphylaxis; therefore, individuals with a known hypersensitivity to cephalosporins or penicillins should exercise extreme caution and consult their healthcare provider immediately.
Prior to initiating therapy, patients should inform their physician of any history of kidney disease, as dosage adjustments may be necessary based on renal function. Concurrent use with other nephrotoxic drugs should be avoided unless closely monitored. Pregnant or breastfeeding women should only use this medication if clearly needed and under strict medical supervision. Additionally, Ceftazidime does not treat viral infections like the common flu. Proper storage at room temperature away from moisture and light is essential to maintain drug stability. Always follow the specific instructions provided by a licensed healthcare professional regarding administration and potential drug interactions to ensure safe and effective treatment outcomes.